RePORT International Highlights

The Workshop will be held as a hybrid meeting from 4-5 December 2025, in San Francisco, US. The deadline for abstract submission is 5 September 2025.

APPLICATION DEADLINE: 1 December, 2025 11:59 p.m. ET The American Lung Association Catalyst Award is a mentored award meant to support outstanding investigators on the path to independence for research into the mechanisms of lung disease and general lung biology. Preference is given to projects that are novel, innovative in design/approach, utilize modern technologies, and incorporate a multidisciplinary collaborative training plan. The Catalyst Grant is for $50,000 per year, for up to two years. Grants are subject to annual review; the second year of support is based upon demonstration of satisfactory progress. When applicable, researchers are encouraged to investigate hypothesis‐driven research that will inform evidence‐based clinical practice or policy in communities across the United States. Proposals can include examining the cause and prevention of lung diseases like tuberculosis, asthma, COPD, and lung cancer, as well as management of lung disease.

The call for conference projects and publications covers all the thematic fields of the agency: - All research on HIV/AIDS, sexually transmitted infections (STIs), viral hepatitis, tuberculosis, including research on their co-infections; - Research on emerging and re-emerging infectious diseases, including arboviruses, respiratory viruses and viral hemorrhagic fevers. It is now possible to submit an application for funding continuously throughout the year, according to the following forecast schedule: January 15 – April 30 May 1 – August 31 September 1 – December 15

Submission Status: OPEN Submission Deadline: ONGOING Journal of Clinical Microbiology® (JCM) welcomes contributions to a Special Series on Diagnostic Testing for Mycobacteria. Tuberculosis is currently the world’s top infectious killer, and non-tuberculous mycobacteria (NTM) infections are also on the rise. Mycobacterial infections are more common in low-income nations and in patients with chronic health conditions. Accessible and accurate diagnosis of these infections is needed to guide effective treatment in these vulnerable patients. What We’re Looking for We welcome studies about the following: Inexpensive and accurate tests for tuberculosis, particularly tests that reduce the barriers of sputum-based diagnostics. Novel whole genome sequencing approaches to improve care of patients with tuberculosis through prediction of antimicrobial susceptibility and to improve rapid investigation of the spread of M. tuberculosis. Novel methods for rapid diagnostic testing for non-tuberculosis mycobacteria and for detection of antimicrobial resistance in mycobacteria (including non-tuberculosis and rapid-growing mycobacteria). Improved and novel diagnostics, including non-invasive tests, for extra-pulmonary tuberculosis. Suggested article types: Full-Length Text* New-Data Letter* Minireview** Commentary**

SUBMISSION CYCLE: 1 December, 2025 to 2 January, 2026 The Conference on Retroviruses and Opportunistic Infections (CROI) showcases the latest and most impactful research on HIV, hepatitis viruses, and their related conditions. Studies on SARS-CoV-2, including Long COVID, and MPXV are also eligible for submission and presentation. Abstracts are selected based on their scientific and medical significance, timeliness, quality of data and methodology, and adherence to the guidelines. Studies with data analyzed after the General Abstract submission deadline are eligible for Late-Breaking Abstract submission if they meet a high threshold of scientific merit. These abstracts must be submitted through the CROI 2026 Dashboard by January 2, 2026.

The Conference on Retroviruses and Opportunistic Infections (CROI) was established in 1993 to provide a forum for basic scientists and clinical investigators to present, discuss, and critique their investigations into the epidemiology and biology of human retroviruses and associated diseases. The synergy of basic science and clinical investigation has been a major contributor to the success of the meeting. CROI has facilitated the presentation of important discoveries in the field, thereby accelerating progress in HIV and AIDS research. CROI highlights the latest research in HIV, hepatitis viruses, SARS-CoV-2 (including long COVID), mpox, and their related conditions. Abstracts are evaluated by the Scientific Program Committee and additional reviewers for the relevance of their topics, the rigor of their research, and the distinct contributions they make to the broad spectrum of study that CROI strives to provide each year. Attendance at the conference is open to researchers and clinical educators actively involved in the study and management of HIV, other retroviruses, and related medical conditions. Limited space is also available to members of the media whose work aligns with the scientific and educational aims of the conference. The 32nd CROI, held from February 22 to 25, 2026, is planned as an in-person conference in Denver, Colarado, USA.

APPLICATION DEADLINE: 30 November, 2025. To equip and empower more leaders in global health, together the Harvard Global Health Institute and the Department of Global Health and Population at Harvard T.H. Chan School of Public Health offer a transformational 1-year fellowship specifically designed to promote leadership skills in individuals from low- and middle-income countries who will, in turn, mentor future female leaders in global health. Candidates should be currently based/working in a LMIC, and plan to return there after their fellowship. Applications for the 2026-2027 cohort are NOW OPEN! All application materials are due by 11:59PM EST, Sunday, November 30th, 2025.

APPLICATION DEADLINE: 1 December, 2025. The Belfer Center offers academic and professional track fellowships during the academic year. Fellows receive direct access to faculty members and other affiliated experts and are joined by a cohort of fellows in the fields of science and international affairs.

APPLICATION DEADLINE: 1 December, 2025 The Commonwealth Fund Fellowship in Health Policy Leadership at Harvard University is a one-year, full-time, academic degree-granting program designed to prepare physicians to become leaders who improve the health for all, with emphasis on disadvantaged, vulnerable, and uninsured populations. We seek applications from highly motivated individuals with great potential for leadership and for becoming change agents in health care delivery systems. Eligibility 1. Physicians who have completed residency in the U.S., either BE/BC. Additional experience beyond residency, such as chief residency, is preferred. 2. Experience or interest in advancing systems change to improve the health of all, with emphasis on disadvantaged, vulnerable, and uninsured populations. 3. Strong evidence of leadership experience or potential, especially as related to community efforts, quality improvement, transformation of health care delivery systems, and/or health policy. Intention to pursue a career in policy, public service, and/or academia. 4. U.S. citizenship or U.S. permanent residency.

APPLICATION DEADLINE: 15 February, 2026 The Weatherhead Scholars Program at the Weatherhead Center for International Affairs invites applications for its 2026–2027 Practitioner Fellowship, a one-year, residential opportunity for accomplished professionals from across the globe who are working on international, comparative, transnational, or global issues. Practitioner fellows join a multidisciplinary cohort—including postdoctoral researchers and visiting faculty—in residence at Harvard for the academic year. The program fosters a dynamic intellectual community through a weekly seminar, professional development workshops, and engagement with the broader Weatherhead Center and Harvard communities. Fellows are expected to be on campus from late August through mid-May and to participate actively in program activities.

The JHU TRAC has partnered with RePORT International to offer Hopkins affiliates and their mentees the opportunity to enroll in JHU CANVAS asynchronous TB research courses. Select from the following courses: Epidemiology for TB Professional Development: Starting and Building Your Research Career Immunology for TB Introduction to Data Visualization Introduction to R Programming

Application due date: Multiple dates, see announcement

Application due date: Multiple dates, see announcement

Application due date: Multiple dates, see announcement

Expected Dates Start date: The position is expected to start as soon as possible. Duration: This is a one-year term position from the date of hire, with the possibility of extension, contingent upon work performance, business need, and continued funding to support the position. We invite applications for a Research Associate position in SBGrid at Harvard Medical School. This annually appointed academic role advances discovery in structural biology by curating, validating, and benchmarking the software that underpins structure determination. You will collaborate with investigators and SBGrid engineers to design scientifically grounded tests, codify reproducible environments, and drive community standards, leveraging Python and shell scripting to automate builds, packaging, and CI/CD. You will contribute to methods, training, and publications that strengthen computational rigor across cryo-EM, crystallography, NMR, and related modalities. SBGrid is a research software platform and global consortium in Harvard Medical School's Department of Biological Chemistry and Molecular Pharmacology. We build, install, and rigorously curate 600+ encapsulated, ready-to-run applications spanning crystallography, cryo-EM, NMR, visualization, computational chemistry, and supporting tools, delivered across on-premises and cloud environments for hundreds of laboratories worldwide. Our Capsule Software Execution Environment (“Capsules”) isolates every application with its exact dependencies, providing zero-configuration, conflict-free execution on 64-bit Linux and Intel/ARM macOS. The collection includes 56,000+ executables, 510,000+ dynamic libraries, and a mix of open-source and academic licenses, with 220+ titles under OSI licenses; our unified licensing streamlines research use. SBGrid releases updates monthly and maintains a modular installation manager that now supports thousands of active installations (3,752 at last count), enabling seamless, secured updates for labs and individual users alike. The platform advances FAIR/FAIR4RS software goals and reproducible research across heterogeneous systems; our BioGrids collection extends these methods beyond structural biology to 700+ computational biology titles.

RSTMH Global Research in Progress is an online meeting designed for early-career investigators worldwide to present and discuss their unpublished research with peers and senior experts in tropical medicine and global health. This meeting is free to attend for RSTMH members and Fellows, and just £10 for non-members.

Reviewers have a crucial role in ensuring that the research published in our journals, Transactions and International Heath, is novel, high quality, and accurate. Reviewing for the RSTMH journals allows you to contribute to the advancement of tropical medicine and global health while at the same time learning about the latest developments in the field before everyone else.

APPLICATION DEADLINE: 1 February, 2026 The sub-Saharan Africa Health Research and Innovation Fellowship Program (SAHRI Fellowship Program) is an exceptional 3-year training program designed to empower 12 talented mid-career biomedical and clinical researchers from sub-Saharan Africa to become leaders in biomedical innovation and clinical research addressing the urgent challenges of infectious diseases across the continent. This fully-funded fellowship features three key phases: - advanced academic training in a research-oriented Master of Science in Tropical Medicine, - hands-on placements at premier African research institutions and BioNTech, and - a strategic return-home implementation phase The application opened on 1 October, 2025.

The world's largest lung health conference, the World Conference on Lung Health, will take place at the Bella Center in Copenhagen, Denmark from 18-21 November 2025.